arrow
J

Jimee Hwang

Centers for Disease Control and Prevention
H指数:37
被引数:4,790

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Extending the Duration of Artemether-Lumefantrine Treatment for Uncomplicated Plasmodium falciparum Malaria: Updated US Centers for Disease Control and Prevention Guidance Based on Review of Surveillance, Consultations, and Published Data

延长青蒿琥酯-本芴醇治疗无并发症恶性疟的疗程:基于监测、咨询和已发表数据评审的美国疾病控制与预防中心更新指南

2026-08-190
OAAI
Haematologic responses to primaquine used for radical cure of Plasmodium vivax in public health facilities in Ethiopia: a prospective observational study

用于治疗埃塞俄比亚公共卫生设施中恶性疟原虫根治性治疗的伯氨喹啉的血学反应:一项前瞻性观察研究

2025-12-080
PRE
An observational study evaluating the epidemiological and entomological impacts of piperonyl butoxide insecticide-treated nets (ITNs) compared to a combination of indoor residual spraying (IRS) plus standard pyrethroid-only ITNs in Amhara Region, Ethiopia, 2019-2023
2025-01-290
OAAI
Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysis

Primaquine治疗15岁以下儿童的非复杂性间日疟: 系统评价和个体患者数据荟萃分析

2024-11-011
OAAI
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis

Primaquine剂量和无并发症的间日疟患者的溶血风险: 系统评价和个体患者数据荟萃分析

2024-02-0112
OAAI
Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta

伯喹剂量对无并发症间日疟患者复发风险的影响: 系统评价和个体患者数据meta

2024-02-0113
OAAI
Evidence for a role of Anopheles stephensi in the spread of drug- and diagnosis-resistant malaria in Africa
2023-10-2638
OAAI
The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
2019-08-0134
OAAI
The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis
2018-09-0184
OAAI
Safety of Single-Dose Primaquine in G6PD-Deficient and G6PD-Normal Males in Mali Without Malaria: An Open-Label, Phase 1, Dose-Adjustment Trial
2018-01-1219
OAAI
Capacity Development through the US President's Malaria Initiative-Supported Antimalarial Resistance Monitoring in Africa Network
2017-12-0122
OAAI
Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trial
2016-06-0175
OAAI